SEC Filing Summary: Inpixon (INPX) Form 8-K
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Inpixon (the "Company") on December 13, 2019. The filing discloses a material definitive agreement involving the exchange of debt for equity and the results of a reconvened annual meeting of stockholders held on the same date.
Key Financial Metrics and Capital Structure
- Debt Exchange: The Company entered into an agreement to exchange $120,000 of outstanding promissory note principal held by Chicago Venture Partners, L.P. ("CVP") for 3,000,000 shares of Common Stock at an effective price of $0.04 per share.
- Outstanding Debt: As of December 11-13, 2019, CVP held approximately $4.15 million in promissory notes. Affiliates Iliad Research and Trading, L.P. and St. George Investments LLC held approximately $1.19 million and $957,500, respectively.
- Capitalization: As of December 13, 2019, the Company had 107,939,581 shares of Common Stock issued and outstanding (including the newly issued shares). Additional securities include 1 share of Series 4 Convertible Preferred Stock, 126 shares of Series 5 Convertible Preferred Stock, and warrants to purchase up to 326,500 shares of Common Stock.
- Liquidity and Margins: The filing text does not provide specific values for revenue, profit, cash flow, or operating margins.
Material Changes and Corporate Actions
- Debt-to-Equity Conversion: A portion of the Company's debt obligation to CVP was converted into equity, reducing the outstanding note balance by $120,000 and increasing the share count by 3,000,000.
- Failed Authorization Increase: At the reconvened annual meeting, stockholders voted on a proposal to increase authorized Common Stock from 250,000,000 to 500,000,000. The proposal was not approved.
- Voting Results: Of the 27,446,819 shares present (63.73% of voting power), 19,304,304 voted "For," 7,283,561 voted "Against," and 858,954 abstained.
Outlook, Risks, and Unusual Items
- Unregistered Sale: The issuance of the 3,000,000 shares was conducted as an unregistered sale in reliance on Section 3(a)(9) of the Securities Act of 1933, as it involved an exchange of securities without additional consideration or commissions.
- Shareholder Approval Risk: The failure to increase the authorized share count may limit the Company's ability to issue additional shares for future financing or acquisitions without further shareholder approval.
- Concentration of Debt: A significant portion of the Company's outstanding debt is held by CVP and its affiliates, representing a concentration risk.
Investor Verification Checklist
- Verify the total outstanding debt balance and interest terms with CVP and its affiliates following the $120,000 reduction.
- Confirm the impact of the failed authorized share increase on the Company's ability to execute future capital raises.
- Review the full text of the Exchange Agreement (Exhibit 10.1) for any additional covenants or conditions attached to the debt conversion.
- Monitor the Company's cash position and liquidity given the high level of outstanding promissory notes relative to the equity raised in this transaction.